Rani Therapeutics Holdings Inc (RANI)
5.40
+0.28
(+5.47%)
USD |
NASDAQ |
May 31, 16:00
5.38
-0.02
(-0.37%)
After-Hours: 20:00
Rani Therapeutics Holdings Price to Book Value: 19.20 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 19.20 |
| May 30, 2024 | 18.20 |
| May 29, 2024 | 17.78 |
| May 28, 2024 | 16.36 |
| May 24, 2024 | 15.79 |
| May 23, 2024 | 17.53 |
| May 22, 2024 | 18.63 |
| May 21, 2024 | 18.28 |
| May 20, 2024 | 18.67 |
| May 17, 2024 | 18.56 |
| May 16, 2024 | 19.41 |
| May 15, 2024 | 19.66 |
| May 14, 2024 | 20.55 |
| May 13, 2024 | 21.72 |
| May 10, 2024 | 22.44 |
| May 09, 2024 | 24.11 |
| May 08, 2024 | 25.42 |
| May 07, 2024 | 26.52 |
| May 06, 2024 | 26.88 |
| May 03, 2024 | 25.42 |
| May 02, 2024 | 22.65 |
| May 01, 2024 | 22.65 |
| April 30, 2024 | 22.68 |
| April 29, 2024 | 23.82 |
| April 26, 2024 | 23.75 |
| Date | Value |
|---|---|
| April 25, 2024 | 23.32 |
| April 24, 2024 | 24.85 |
| April 23, 2024 | 23.78 |
| April 22, 2024 | 23.71 |
| April 19, 2024 | 25.13 |
| April 18, 2024 | 21.51 |
| April 17, 2024 | 27.91 |
| April 16, 2024 | 24.42 |
| April 15, 2024 | 20.48 |
| April 12, 2024 | 19.20 |
| April 11, 2024 | 15.89 |
| April 10, 2024 | 14.79 |
| April 09, 2024 | 14.22 |
| April 08, 2024 | 13.26 |
| April 05, 2024 | 13.15 |
| April 04, 2024 | 13.37 |
| April 03, 2024 | 11.77 |
| April 02, 2024 | 11.16 |
| April 01, 2024 | 11.12 |
| March 28, 2024 | 6.295 |
| March 27, 2024 | 6.133 |
| March 26, 2024 | 6.436 |
| March 25, 2024 | 6.548 |
| March 22, 2024 | 6.598 |
| March 21, 2024 | 7.286 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.305
Minimum
Sep 29 2023
27.91
Maximum
Apr 17 2024
6.276
Average
4.851
Median
Nov 30 2022
Price to Book Value Benchmarks
| Kodiak Sciences Inc | 0.6927 |
| CEL-SCI Corp | 4.581 |
| AIM ImmunoTech Inc | 4.487 |
| IGC Pharma Inc | 3.428 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 45.73 |
| Price | 5.40 |
| Earnings Yield | -23.89% |
| Market Cap | 142.04M |
| Normalized PE Ratio | 138.10 |